Skip to main content
. 2018 Jan 2;9(6):7066–7074. doi: 10.18632/oncotarget.23829

Table 5. Haplotype analysis for genotypes of HLA-DP/DQ and IgAN risk.

Haplotypes Case (freq.) Control (freq.) OR (95%CI) p
AAA 11.50 (0.041) 50.15 (0.051) 0.81 (0.42~1.56) 0.526019
AAG 64.41 (0.230) 174.03 (0.178) 1.42 (1.03~1.96) 0.033938
AGG 40.29 (0.144) 95.49 (0.097) 1.59 (1.07~2.36) 0.020488
GAG 73.31 (0.262) 131.98 (0.135) 2.34 (1.69~3.24) 1.67E-07
GGA 7.91 (0.028) 58.67 (0.060) 0.46 (0.22~0.99) 0.041992

OR: odds ratio; CI: confidence interval; IgAN: IgA nephropathy.

Order of HLA haplotype block: rs3077 (minor allele A), rs9277535 (minor allele A) and rs7453920 (minor allele A).

Bold values are statistically significant (p < 0.05).